Radiopeptide therapy improves survival outcomes for neuroendocrine cancer patients
Peptide-receptor radionuclide therapy (PRRT) has been a subject of growing research on neuroendocrine tumors, which take up residence in a variety of organs replete with nerve cells that respond to hormone signaling. A countrywide ...
Jun 11, 2013
0
3